GlassScriptPhysician profile
Shane L Barney
NPI 1659759819
$1,621.12
in general payments reported to CMS, 2019-2025
19 companies · $472 in 2025
The $472 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.83 · 2022: $392 · 2024: $740 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $610.52 | 2022-2024 | Urolift |
| Coloplast Corp | $146.89 | 2024 | |
| Axonics, INC. | $120.36 | 2022-2024 | Axonics |
| Procept Biorobotics Corporation | $103.81 | 2024 | Aquabeam System |
| Sumitomo Pharma America, INC. | $96.63 | 2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $67.30 | 2024-2025 | Erleada, Akeega |
| Novartis Pharmaceuticals Corporation | $66.71 | 2025 | |
| Urogen Pharma, INC. | $64.18 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $62.94 | 2025 | Provenge |
| Astellas Pharma US INC | $52.95 | 2025 | Xtandi |
| Boston Scientific Corporation | $50.01 | 2025 | Ams 700 |
| Agiliti Surgical, INC. | $31.59 | 2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu |
| Tolmar, INC. | $24.23 | 2024 | |
| Myriad Genetic Laboratories, INC. | $24.07 | 2024 | Prolaris |
| Merck Sharp & Dohme LLC | $23.15 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $22.49 | 2025 | Tlando |
| Ferring Pharmaceuticals INC. | $18.87 | 2024 | Adstiladrin |
| Blue Earth Diagnostics | $17.59 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $16.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Barney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.